March Biosciences
Houston, US · Founded 2021 · Delaware corporation · 8 known investors
Find your way into March Biosciences
119 people in our graph share verified history with the March Biosciences team — schools, employers, funds. One of them is your warm intro.
Edi Danalacheunlockedknows Sarah Hein · together at Rice University (overlapped)
×10knows the team · via Mercury Fund
knows the team · via Baylor College of Medicine
March Bioscience is a cell therapy company assembling leading scientists and drug developers to advance cell therapy treatments. The company focuses on developing therapeutics in the cell and gene therapy space.
Founders & leadership
March Biosciences was founded in 2021 by Sarah Hein, Maksim Mamonkin, and Malcolm Brenner.
SH
Sarah HeininCEO, Co-FounderShe previously served as VP of Operations at Courier Therapeutics (acquired by Valo Health), held research and accelerator roles at Resonant Therapeutics and Texas Medical Center Innovation Accelerator, and began her career as a venture fellow at Mercury Fund following her PhD in Molecular Biology from Baylor College of Medicine.
MM
Maksim MamonkinCo-Founder, Chair Scientific Advisory Board
MB
Malcolm BrennerCo-founder
Board
Investors · 8
Reported raises · per SEC filings
Form D private placements$22.1M disclosed across 2 rounds · 2023–2024
▶$22.1MraisedOct 2024 · 22 investors · BiotechnologyRule 506(b)
▶$22.1MraisedOct 2024 · 22 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Thomas LubyDirector
- Peter OlagunjuDirector
- Joseph PetrosinoDirector
- Sarah HeinDirector, Executive Officer
- Maksim MamonkinDirector, Executive Officer
- Offering amount
- $22.1M
- Amount sold
- $22.1M
- First sale
- Oct 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$8.9KraisedSep 2023 · 1 investors · BiotechnologyRule 506(b)
▶$8.9KraisedSep 2023 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sarah HeinExecutive Officer, Director
- Offering amount
- $8.9K
- Amount sold
- $8.9K
- Minimum investment
- $8.9K
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlap
bio11 shared keywordsBIO is the world's largest advocacy association representing biotechnology companies and research institutions across the United States and 30+ other nations. The organization facilitates industry networking through events, conferences, and partnering software while providing cost-savings programs and advocacy services for member companies.
Solid Biosciences10 shared keywordsSolid Biosciences is a precision genetic medicine company developing a pipeline of gene therapy candidates for rare neuromuscular and cardiac diseases, including Duchenne muscular dystrophy, Friedreich's ataxia, CPVT, and TNNT2-mediated dilated cardiomyopathy. It also develops genetic regulator libraries and delivery platform technologies intended to improve gene therapy delivery.
Mammoth Biosciences10 shared keywordsMammoth Bio develops technology to read and write the code of life, operating in the biotechnology sector.
Mission BioCapital Platinum Program Holdings LLC9 shared keywordsMission BioCapital is a venture capital firm that invests in early-stage life science companies, from therapeutics and drug discovery to biotech tools and diagnostics. The firm provides capital, operational support, and lab infrastructure through its MBC BioLabs co-working spaces to help scientific entrepreneurs launch and scale biotech startups.
Companies competing with March Biosciences for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does March Biosciences do?
- March Bioscience is a cell therapy company assembling leading scientists and drug developers to advance cell therapy treatments. The company focuses on developing therapeutics in the cell and gene therapy space.
- Who founded March Biosciences?
- March Biosciences was founded by Sarah Hein, Maksim Mamonkin, Malcolm Brenner in 2021.
- Who are March Biosciences's investors?
- March Biosciences's investors include Mission Biocapital, 4BIO Capital, Cancer Fund, Fitz Gate Ventures, Modi Ventures, Portal Innovations, TMC Venture Fund, KdT Ventures.
- How much funding has March Biosciences raised?
- March Biosciences has disclosed $22.1M raised across 2 rounds.
- Where is March Biosciences headquartered?
- March Biosciences is headquartered in Houston, US.